1. Balbuena-Merle RI, Nazario-Delgado CM, Rosario-Rosado RV, Millán-Tapia D, Climent-Peris C. Red blood cell alloimmunization in the pediatric sickle cell disease population of the Puerto Rico: an observational study. Ann Lab Med. 2020; 40:187–189. PMID:
31650739.
2. Kim HY, Cho EJ, Chun S, Kim KH, Cho D. Red blood cell alloimmunization in Korean patients with myelodysplastic syndrome and liver cirrhosis. Ann Lab Med. 2019; 39:218–222. PMID:
30430787.
3. Samarah F, Srour MA, Yaseen D, Dumaidi K. Frequency of red blood cell alloimmunization in patients with sickle cell disease in Palestine. Adv Hematol. 2018; 2018:5356245. PMID:
29977298.
4. Cheng CK, Lee CK, Lin CK. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review. Transfusion. 2012; 52:2220–2224. PMID:
22339270.
5. Shin KH, Lee HJ, Kim HH, Hong YJ, Park KU, Kim MJ, et al. Frequency of red blood cell antigens according to parent ethnicity in Korea using molecular typing. Ann Lab Med. 2018; 38:599–603. PMID:
30027705.
6. U.S. Census Bureau. American Community Survey and Puerto Rico Community Survey, 2013-2017 American Community Survey 5-Year Estimates, Table DP05, generated using American FactFinder. Updated on Sep 2019.
http://factfinder.census.gov.
7. Ameen R, Al Shemmari S, Al-Bashir A. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion. Transfusion. 2009; 49:1649–1654. PMID:
19453992.
8. Fasano RM, Meyer EK, Branscomb J, White MS, Gibson RW, Eckman JR. Impact of red blood cell antigen matching on alloimmunization and transfusion complications in patients with sickle cell disease: a systematic review. Transfus Med Rev. 2019; 33:12–23. PMID:
30122266.
10. Han KS, Park KU, et al. Transfusion Medicine. 4th ed.Korea Medical Book Publishing Company;2014. p. 212–223.